Meghan Markle Invests In $63M Midi Health Round As Top Women From OpenAI, Google, Meta, And Hollywood Rally Behind Menopause Care

Midi Health, a rising player in women’s healthcare, just closed a $63 million Series B funding round with Meghan Markle joining a star-powered list of investors. The virtual healthcare startup, focused on menopause and midlife health support, also gained backing from names like comedian Amy Schumer, “White Lotus” star Connie Britton, and fashion icon Tory Burch.

The investment marks another strategic move for Markle, who has spent the past five years quietly building a portfolio focused on purpose-driven companies with female leadership at the forefront. According to TechCrunch, other investors in this latest round include Laurene Powell Jobs' Emerson Collective and G9 Ventures. Other major figures from companies like OpenAI, Alphabet GOOGL GOOG)), Apple AAPL, Amazon AMZN, and Meta META have also invested in Midi Health.

Don't Miss:

‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.26/share with a $1000 minimum.
Invest in the future of digital engagement: Own a piece of the $100 billion Metaverse for just $500.

How Meghan Markle Is Quietly Redefining Women's Entrepreneurship

Midi Health offers digital clinical care for women aged 35 and over, addressing menopause symptoms and other midlife health concerns. The company aims to close the major gap in healthcare options for this demographic. About 40% of Midi's team identifies as people of color, reinforcing the company’s commitment to providing culturally responsive care.

Speaking to Fortune, Markle encouraged women to engage more openly with finance. "Women need to see that they can build," she said. "Women don't need to be afraid to talk about finance. And I think the more financial literacy we have, the stronger we're going to be."

The Series B round saw 80 investors contributing between $10,000 and $500,000 each, with a clear focus on aligning with Midi Health's mission to empower women. In a statement, Midi Health highlighted that the group of investors included women leaders from industries spanning entertainment, professional sports, media, technology, and business.

Trending: With shares starting at $1.52, this could be your chance to invest in the future of healthcare.

Meghan Markle's Investment Map

Markle's growing angel investment portfolio now spans over ten companies, with a strong emphasis on brands led by women and those prioritizing wellness, health, and education. Previous investments include wellness-focused companies like Clevr, a beverage brand she's supported since 2020, and Highbrow Hippie.

Midi Health's service model is structured for both insured and self-paying patients. The startup’s virtual care system is designed to make expert menopause support more accessible to women across the U.S., offering personalized treatment plans through a team of specialized clinicians.

Markle's partnership with Midi Health comes at a time when women's health startups are gaining more attention from both investors and the public. According to a Silicon Valley Bank report, women's health investment hit $2.6 billion last year, surpassing 2023's total by nearly $1 billion. The startup's strategic growth aligns with broader market trends pushing for better healthcare solutions tailored to women's specific needs.

See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — invest pre-IPO from $0.60 per share now.

Building A New Empire Across The Atlantic

Since relocating to the U.S. and stepping away from royal duties, Markle and her husband, Prince Harry, have been steadily building a business presence, investing significant sums into various American startups. Their portfolio reflects a vision of supporting companies that drive social impact and champion underrepresented communities.

Midi Health’s latest funding round secures the company’s future growth and also signals a larger shift in the healthcare landscape. With names like Markle leading the way, the conversation around women’s midlife health is finally taking center stage.

Read Next: